1. Home
  2. AIN vs HRMY Comparison

AIN vs HRMY Comparison

Compare AIN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Albany International Corporation

AIN

Albany International Corporation

HOLD

Current Price

$59.81

Market Cap

1.6B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$31.36

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIN
HRMY
Founded
1895
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
AIN
HRMY
Price
$59.81
$31.36
Analyst Decision
Hold
Buy
Analyst Count
4
9
Target Price
$60.25
$44.11
AVG Volume (30 Days)
199.3K
890.5K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
1.93%
N/A
EPS Growth
N/A
7.97
EPS
0.54
0.55
Revenue
$1,054,132,000.00
$868,453,000.00
Revenue This Year
$1.20
$19.75
Revenue Next Year
N/A
$12.88
P/E Ratio
$111.61
$55.13
Revenue Growth
7.29
21.51
52 Week Low
$41.15
$25.52
52 Week High
$73.00
$40.87

Technical Indicators

Market Signals
Indicator
AIN
HRMY
Relative Strength Index (RSI) 52.63 55.43
Support Level $53.47 $28.26
Resistance Level $60.14 $33.11
Average True Range (ATR) 1.99 1.13
MACD -0.16 -0.16
Stochastic Oscillator 45.77 60.99

Price Performance

Historical Comparison
AIN
HRMY

About AIN Albany International Corporation

Albany International Corp is a textiles and materials processing company specializing in engineered fabrics and composite components and assemblies for the paper, industrial manufacturing and aerospace industries. It operates through two segments: Machine Clothing, which produces custom-designed fabrics and high-speed process belts for paper, paperboard, tissue, towel and pulp, as well as engineered fabrics for other industrial applications, and contributes the majority of revenue; and Albany Engineered Composites, which provides engineered composite parts for the aerospace and defense industries. The company generates revenue from the United States, Switzerland, Brazil, China, Mexico, France and other areas.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: